These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease. Ghosh A; Roy A; Matras J; Brahmachari S; Gendelman HE; Pahan K J Neurosci; 2009 Oct; 29(43):13543-56. PubMed ID: 19864567 [TBL] [Abstract][Full Text] [Related]
3. Regulation of striatal astrocytic receptor for advanced glycation end-products variants in an early stage of experimental Parkinson's disease. Viana SD; Valero J; Rodrigues-Santos P; Couceiro P; Silva AM; Carvalho F; Ali SF; Fontes-Ribeiro CA; Pereira FC J Neurochem; 2016 Aug; 138(4):598-609. PubMed ID: 27221633 [TBL] [Abstract][Full Text] [Related]
5. Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice. Wang Q; Shin EJ; Nguyen XK; Li Q; Bach JH; Bing G; Kim WK; Kim HC; Hong JS J Neuroinflammation; 2012 Jun; 9():124. PubMed ID: 22695044 [TBL] [Abstract][Full Text] [Related]
6. Enhanced dopaminergic neurotoxicity mediated by MPTP in IL-32β transgenic mice. Jung YY; Katila N; Neupane S; Shadfar S; Ojha U; Bhurtel S; Srivastav S; Son DJ; Park PH; Yoon DY; Hong JT; Choi DY Neurochem Int; 2017 Jan; 102():79-88. PubMed ID: 27956238 [TBL] [Abstract][Full Text] [Related]
7. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA. Choi DC; Chae YJ; Kabaria S; Chaudhuri AD; Jain MR; Li H; Mouradian MM; Junn E J Neurosci; 2014 Sep; 34(38):12725-37. PubMed ID: 25232110 [TBL] [Abstract][Full Text] [Related]
9. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration. Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659 [TBL] [Abstract][Full Text] [Related]
10. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Aoki E; Yano R; Yokoyama H; Kato H; Araki T Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004 [TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity. Oeckl P; Ferger B Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149 [TBL] [Abstract][Full Text] [Related]
13. RAGE and its emerging role in the pathogenesis of Parkinson's disease. Jiang X; Wang X; Tuo M; Ma J; Xie A Neurosci Lett; 2018 Apr; 672():65-69. PubMed ID: 29477598 [TBL] [Abstract][Full Text] [Related]
14. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration. Choi DY; Lee MK; Hong JT Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease. Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448 [TBL] [Abstract][Full Text] [Related]
16. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092 [TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease. Stahl K; Rahmani S; Prydz A; Skauli N; MacAulay N; Mylonakou MN; Torp R; Skare Ø; Berg T; Leergaard TB; Paulsen RE; Ottersen OP; Amiry-Moghaddam M PLoS One; 2018; 13(3):e0194896. PubMed ID: 29566083 [TBL] [Abstract][Full Text] [Related]
18. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration. Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA Mol Neurobiol; 2017 Oct; 54(8):6148-6162. PubMed ID: 27704331 [TBL] [Abstract][Full Text] [Related]
19. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease. Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060 [TBL] [Abstract][Full Text] [Related]
20. RAGE Silencing Ameliorates Neuroinflammation by Inhibition of p38-NF-κB Signaling Pathway in Mouse Model of Parkinson's Disease. Wang X; Sun X; Niu M; Zhang X; Wang J; Zhou C; Xie A Front Neurosci; 2020; 14():353. PubMed ID: 32410941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]